Danielczyk A - Search Results

1

Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.

Goletz C, Lischke T, Harnack U, Schiele P, Danielczyk A, Rühmann J, Goletz S. Goletz C, et al. Among authors: danielczyk a. Front Immunol. 2018 Jul 16;9:1614. doi: 10.3389/fimmu.2018.01614. eCollection 2018. Front Immunol. 2018. PMID: 30061887 Free PMC article.

2

Thomsen-Friedenreich antigen: the "hidden" tumor antigen.

Goletz S, Cao Y, Danielczyk A, Ravn P, Schoeber U, Karsten U. Goletz S, et al. Among authors: danielczyk a. Adv Exp Med Biol. 2003;535:147-62. doi: 10.1007/978-1-4615-0065-0_10. Adv Exp Med Biol. 2003. PMID: 14714894 Review. No abstract available.

3

Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).

Karsten U, Serttas N, Paulsen H, Danielczyk A, Goletz S. Karsten U, et al. Among authors: danielczyk a. Glycobiology. 2004 Aug;14(8):681-92. doi: 10.1093/glycob/cwh090. Epub 2004 Apr 28. Glycobiology. 2004. PMID: 15115750

4

Simple separation of DNA in antibody purification.

Christensen PA, Danielczyk A, Stahn R, Goletz S. Christensen PA, et al. Among authors: danielczyk a. Protein Expr Purif. 2004 Oct;37(2):468-71. doi: 10.1016/j.pep.2004.06.019. Protein Expr Purif. 2004. PMID: 15358372

5

Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.

Ravn P, Danielczyk A, Jensen KB, Kristensen P, Christensen PA, Larsen M, Karsten U, Goletz S. Ravn P, et al. Among authors: danielczyk a. J Mol Biol. 2004 Oct 29;343(4):985-96. doi: 10.1016/j.jmb.2004.08.052. J Mol Biol. 2004. PMID: 15476815

6

PankoMab: a potent new generation anti-tumour MUC1 antibody.

Danielczyk A, Stahn R, Faulstich D, Löffler A, Märten A, Karsten U, Goletz S. Danielczyk A, et al. Cancer Immunol Immunother. 2006 Nov;55(11):1337-47. doi: 10.1007/s00262-006-0135-9. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485130 Free PMC article.

7

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.

Ravn P, Stahn R, Danielczyk A, Faulstich D, Karsten U, Goletz S. Ravn P, et al. Among authors: danielczyk a. Cancer Immunol Immunother. 2007 Sep;56(9):1345-57. doi: 10.1007/s00262-007-0292-5. Epub 2007 Feb 20. Cancer Immunol Immunother. 2007. PMID: 17310382 Free PMC article.

8

A monoclonal antibody to Lewis Y/Lewis b revealing mimicry of the histone H1 to carbohydrate structures.

Christensen PA, Danielczyk A, Ravn P, Stahn R, Karsten U, Goletz S. Christensen PA, et al. Among authors: danielczyk a. Scand J Immunol. 2007 Apr;65(4):362-7. doi: 10.1111/j.1365-3083.2007.01913.x. Scand J Immunol. 2007. PMID: 17386027 Free article.

9

Modifying antibody specificity by chain shuffling of V / V between antibodies with related specificities.

Christensen PA, Danielczyk A, Ravn P, Larsen M, Stahn R, Karsten U, Goletz S. Christensen PA, et al. Among authors: danielczyk a. Scand J Immunol. 2009 Jan;69(1):1-10. doi: 10.1111/j.1365-3083.2008.02164.x. Scand J Immunol. 2009. PMID: 19140871 Free article.

10

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K₅₂₁ Polymorphism.

Braig F, Kriegs M, Voigtlaender M, Habel B, Grob T, Biskup K, Blanchard V, Sack M, Thalhammer A, Ben Batalla I, Braren I, Laban S, Danielczyk A, Goletz S, Jakubowicz E, Märkl B, Trepel M, Knecht R, Riecken K, Fehse B, Loges S, Bokemeyer C, Binder M. Braig F, et al. Among authors: danielczyk a. Cancer Res. 2017 Mar 1;77(5):1188-1199. doi: 10.1158/0008-5472.CAN-16-0754. Epub 2016 Dec 28. Cancer Res. 2017. PMID: 28031227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page